Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M623Revenue $M1.2Net Margin (%)-3,093.7Z-Score1.7
Enterprise Value $M471EPS $-0.2Operating Margin %-3,149.4F-Score4
P/E(ttm))0Cash Flow Per Share $-0.7Pre-tax Margin (%)-3,093.7Higher ROA y-yN
Price/Book4.710-y EBITDA Growth Rate %-11.6Quick Ratio3.7Cash flow > EarningsY
Price/Sales5265-y EBITDA Growth Rate %-25.8Current Ratio3.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-25.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-28.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M158ROI % (ttm)-57.9Gross Margin Increase y-yN

Gurus Latest Trades with GERN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GERNJean-Marie Eveillard 2014-12-31 Reduce-0.01%$1.85 - $3.84
($2.78)
$ 4.0431%Reduce -48.64%1,128,866
GERNJean-Marie Eveillard 2014-09-30 Reduce-0.01%$2.12 - $3.014
($2.46)
$ 4.0439%Reduce -38.05%2,198,124
GERNJean-Marie Eveillard 2014-03-31 Add0.01%$1.6 - $5.4
($4.04)
$ 4.040%Add 46.43%3,054,252
GERNJean-Marie Eveillard 2013-03-31 Add$1.01 - $1.64
($1.38)
$ 4.0466%Add 36.91%2,410,934
GERNGeorge Soros 2011-03-31 Sold Out $4.44 - $5.07
($4.71)
$ 4.04-17%Sold Out0
GERNJean-Marie Eveillard 2010-12-31 Add0.03%$4.46 - $6.02
($5.23)
$ 4.04-29%Add 74.80%2,570,500
GERNGeorge Soros 2010-12-31 Buy $4.46 - $6.02
($5.23)
$ 4.04-29%New holding26,500
GERNJean-Marie Eveillard 2010-06-30 Add0.02%$4.67 - $5.81
($5.13)
$ 4.04-27%Add 77.56%1,420,500
GERNJean-Marie Eveillard 2010-03-31 Add0.03%$4.97 - $6.21
($5.58)
$ 4.04-38%Add 204.80%800,000
GERNJean-Marie Eveillard 2009-12-31 Add0.02%$4.91 - $6.69
($5.55)
$ 4.04-37%Add 556.18%262,471
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GERN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GERN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hofstaetter ThomasDirector 2015-03-18Sell70,000$4.15.61view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-05-29Sell4,826$2.1106.19view
Bloom Olivia KyusukEVP, CFO 2014-05-29Sell3,379$2.1106.19view
BRADBURY DANIELDirector 2014-05-09Buy142,776$1.75147.43view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-04-01Sell12,310$2.13103.29view
Bloom Olivia KyusukEVP, CFO 2014-04-01Sell7,435$2.13103.29view
SCARLETT JOHN APresident and CEO 2013-04-01Buy50,000$1.03320.39view
BEHRS MELISSA KELLYSVP Alliance and Prog Mgmt 2013-01-17Sell28,292$1.65162.42view
BEHRS MELISSA KELLYSVP Strategic Portfolio Mgmt 2012-05-30Sell18,910$1.37216.06view
Bloom Olivia KyusukVP, Chief Acctg Officer 2012-05-30Sell11,029$1.37216.06view

Press Releases about GERN :

    Quarterly/Annual Reports about GERN:

    News about GERN:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
    WEEKLY CFO SELLS HIGHLIGHT: HTM, OVTI, VSEA, KSWS,GERN, ATRC Jun 20 2011 
    Geron Corp. Reports Operating Results (10-Q) Oct 29 2010 
    Geron: Buyer Beware Oct 13 2010 
    Geron Corp. (GERN) President and CEO Thomas Okarma sells 18,874 Shares Jun 03 2010 
    Geron Corp. (GERN) EVP and CFO David Greenwood sells 14,746 Shares Jun 03 2010 
    Geron Corporation Reports 2009 Second Quarter Financial Results and Events Jul 30 2009 
    Geron Corp (GERN): Stock of the Day Mar 10 2009 
    Banking 60% on the Day the World Changed: FDA Approves Geron to Test Embryonic Stem Cells on Humans Jan 24 2009 
    The Next Boom Emerges Nov 23 2008 


    More From Other Websites
    The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera... Apr 22 2015
    Law Offices of Howard G. Smith Announces Investigation of Geron Corporation Apr 21 2015
    Oppenheimer Is Excited About These 3 Biotech Stocks Apr 21 2015
    Coverage initiated on Geron by Oppenheimer Apr 21 2015
    The Zacks Analyst Blog Highlights: Pfizer, Pharmacyclics, Geron, Anthera Pharmaceuticals and Cytori... Apr 16 2015
    3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog Apr 15 2015
    Geron to Present at the 14th Annual Needham Healthcare Conference Apr 07 2015
    Geron to Present at the 14th Annual Needham Healthcare Conference Apr 07 2015
    Market Has Not Yet Noticed Potential in Geron (GERN); Have You? - Tale of the Tape Apr 07 2015
    GERON CORP Financials Mar 18 2015
    Biotech bull case: MNK & ICPT Mar 13 2015
    Geron Corporation (GERN) Jumps: Stock Rises 5.6% - Tale of the Tape Mar 13 2015
    GERON CORP Files SEC form 10-K, Annual Report Mar 11 2015
    Geron (GERN) Shares March Higher, Can It Continue? - Tale of the Tape Mar 09 2015
    Geron Shares Could Double Mar 05 2015
    Geron's Q4 Loss Narrows Y/Y, Announces Restructuring Plan - Analyst Blog Mar 04 2015
    Geron reports 4Q loss Mar 03 2015
    Geron reports 4Q loss Mar 03 2015
    Q4 & FY 2014 Geron Corp Earnings Call scheduled for 4:30 pm ET today Mar 03 2015
    Geron Corporation Reports Fourth Quarter and Annual 2014 Financial Results and Recent Events Mar 03 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK